| [1] |
GBD 2016 traumatic brain injury and spinal cord injury collaborators. Global, regional, and national burden of spinal cord injury, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet Neurol, 2019, 18(1): 56-87. DOI: 10.1016/S1474-4422(18)30415-0. |
| [2] |
Slanzi A, Iannoto G, Rossi B, et al. In vitro models of neurodegenerative diseases[J]. Front Cell Dev Biol, 2020, 8: 328. DOI: 10.3389/fcell.2020.00328.
|
| [3] |
Dawson TM, Golde TE, Lagier-Tourenne C. Animal models of neurodegenerative diseases[J]. Nat Neurosci, 2018, 21(10): 1370-1379. DOI: 10.1038/s41593-018-0236-8.
|
| [4] |
Marton RM, Pașca SP. Organoid and assembloid technologies for investigating cellular crosstalk in human brain development and disease[J]. Trends Cell Biol, 2020, 30(2): 133-143. DOI: 10.1016/j.tcb.2019.11.004.
|
| [5] |
Lai BQ, Feng B, Che MT, et al. A modular assembly of spinal cord-like tissue allows targeted tissue repair in the transected spinal cord[J]. Adv Sci (Weinh), 2018, 5(9): 1800261. DOI: 10.1002/advs.201800261.
|
| [6] |
Zhu YJ, Huang RQ, Yu LQ, et al. Engineered thoracic spinal cord organoids for transplantation after spinal cord injury[J/OL]. Nat Biomed Eng, 2025, Online ahead of print. DOI: 10.1038/s41551-025-01549-8.
|
| [7] |
Liu LL, Xue WW, Kong YF, et al. Transplantation of engineered spinal cord organoids restores functions after spinal cord injury[J]. Brain, 2025, 9: awaf471. DOI: 10.1093/brain/awaf471.
|
| [8] |
Takata N, Li Z, Metlushko A, et al. Injury and therapy in a human spinal cord organoid[J]. Nat Biomed Eng, 2026, Online ahead of print. DOI: 10.1038/s41551-025-01606-2.
|
| [9] |
Lancaster MA, Renner M, Martin CA, et al. Cerebral organoids model human brain development and microcephaly[J]. Nature, 2013, 501(7467): 373-379. DOI: 10.1038/nature12517.
|
| [10] |
Khong ZJ, Hor JH, Ng SY. Spinal cord organoids add an extra dimension to traditional motor neuron cultures[J]. Neural Regen Res, 2019, 14(9): 1515-1516. DOI: 10.4103/1673-5374.255966.
|
| [11] |
Hor JH, Ng SY. Generating ventral spinal organoids from human induced pluripotent stem cells[J]. Methods Cell Biol, 2020, 159: 257-277. DOI: 10.1016/bs.mcb.2020.03.010.
|
| [12] |
Whye D, Wood D, Kim KH, et al. Dynamic 3D combinatorial generation of hPSC-derived neuromesodermal organoids with diverse regional and cellular identities[J]. Curr Protoc, 2022, 2(10): e568. DOI: 10.1002/cpz1.568.
|
| [13] |
Zhou G, Pang SY, Li YN, et al. Progress in the generation of spinal cord organoids over the past decade and future perspectives[J]. Neural Regen Res, 2024, 19(5): 1013-1019. DOI: 10.4103/1673-5374.385280.
|
| [14] |
Lee JH, Shin H, Shaker MR, et al. Human spinal cord organoids exhibiting neural tube morphogenesis for a quantifiable drug screening system of neural tube defects[PP/OL]. bioRxiv (2020-12-02). https://doi.org/10.1101/2020.12.02.409177.
|
| [15] |
Lee JH, Shin H, Shaker MR, et al. Production of human spinal-cord organoids recapitulating neural-tube morphogenesis[J]. Nat Biomed Eng, 2022, 6(4): 435-448. DOI: 10.1038/s41551-022-00868-4.
|
| [16] |
Gonzalez-Gobartt E, Blanco-Ameijeiras J, Usieto S, et al. Cell intercalation driven by SMAD3 underlies secondary neural tube formation[J]. Dev Cell, 2021, 56(8): 1147-1163. e6. DOI: 10.1016/j.devcel.2021.03.023.
|
| [17] |
Briscoe J, Small S. Morphogen rules: design principles of gradient-mediated embryo patterning[J]. Development, 2015, 142(23): 3996-4009. DOI: 10.1242/dev.129452.
|
| [18] |
Luo T, Liu C, Cheng T, et al. Establishing dorsal-ventral patterning in human neural tube organoids with synthetic organizers[J]. Cell Stem Cell, 2025, 32(7): 1071-1086.e8. DOI: 10.1016/j.stem.2025.04.011.
|
| [19] |
Philippidou P, Dasen JS. Hox genes: choreographers in neural development, architects of circuit organization[J]. Neuron, 2013, 80(1): 12-34. DOI: 10.1016/j.neuron.2013.09.020.
|
| [20] |
Ma L, Zhang Z, Mu YL, et al. Generation of engineered human spinal cord organoid in channel-patterned collagen and transplantation for spinal cord regeneration[J]. Biomaterials, 2026, 327: 123753. DOI: 10.1016/j.biomaterials.2025.123753.
|
| [21] |
Li YH, Gu YF, Wang ZR, et al. Gelma hydrogel encapsulating iPSC-derived human spinal cord organoids enhances neural regeneration and restores motor function in rat spinal cord injury[J]. J Biomed Mater Res A, 2025, 113(10): e38001. DOI: 10.1002/jbm.a.38001.
|
| [22] |
Han G, Lavoie NS, Patil N, et al. 3D-printed scaffolds promote enhanced spinal organoid formation for use in spinal cord injury[J]. Adv Healthc Mater, 2025, 14(24): e04817. DOI: 10.1002/adhm.202404817.
|
| [23] |
Sun Z, Chen ZN, Yin M, et al. Harnessing developmental dynamics of spinal cord extracellular matrix improves regenerative potential of spinal cord organoids[J]. Cell Stem Cell, 2024, 31(5): 772-787.e11. DOI: 10.1016/j.stem.2024.03.007.
|
| [24] |
Andersen J, Revah O, Miura Y, et al. Generation of functional human 3D cortico-motor assembloids[J]. Cell, 2020, 183(7): 1913-1929.e26. DOI: 10.1016/j.cell.2020.11.017.
|
| [25] |
Vieira de Sá R, Cañizares Luna M, Pasterkamp RJ. Advances in Central Nervous System Organoids: A Focus on Organoid-Based Models for Motor Neuron Disease[J]. Tissue Eng Part C Methods, 2021, 27(3): 213-224. DOI: 10.1089/ten.TEC.2020.0337.
|
| [26] |
Ma L, Zhang Z, Mu YL, et al. The application of biomaterial-based spinal cord tissue engineering[J]. Macromol Biosci, 2025, 25(3): e2400444. DOI: 10.1002/mabi.202400444.
|
| [27] |
Huang RQ, Zhu YJ, Chen HK, et al. Progress in spinal cord organoid research: advancing understanding of neural development, disease modelling, and regenerative medicine[J]. Biomater Transl, 2024, 5(4): 355-371. DOI: 10.12336/biomatertransl.2024.04.003.
|
| [28] |
Brown RH, Al-Chalabi A. Amyotrophic Lateral Sclerosis[J]. N Engl J Med, 2017, 377(2): 162-172. DOI: 10.1056/NEJMra1603471.
|
| [29] |
Zhang YX, Chen BH, Li YX, et al. Advances and challenges in the use of spinal cord organoids in ALS[J]. J Integr Neurosci, 2026, 25(2): 44709. DOI: 10.31083/JIN44709.
|
| [30] |
Gao C, Shi QH, Pan X, et al. Neuromuscular organoids model spinal neuromuscular pathologies in C9orf72 amyotrophic lateral sclerosis[J]. Cell Rep, 2024, 43(3): 113892. DOI: 10.1016/j.celrep.2024.113892.
|
| [31] |
Guo RY, Chen YM, Zhang JY, et al. Neural differentiation and spinal cord organoid generation from induced pluripotent stem cells (iPSCs) for ALS modelling and inflammatory screening[J]. Mol Neurobiol, 2024, 61(7): 4732-4749. DOI: 10.1007/s12035-023-03836-4.
|
| [32] |
Tamaki Y, Ross JP, Alipour P, et al. Spinal cord extracts of amyotrophic lateral sclerosis spread TDP-43 pathology in cerebral organoids[J]. PLoS Genet, 2023, 19(2): e1010606. DOI: 10.1371/journal.pgen.1010606.
|
| [33] |
Zhao AD, Pan Y, Cai S. Patient-specific cells for modeling and decoding amyotrophic lateral sclerosis: advances and challenges[J]. Stem Cell Rev Rep, 2020, 16(3): 482-502. DOI: 10.1007/s12015-019-09946-8.
|
| [34] |
Dawoody Nejad L, Pioro EP. Modeling ALS with patient-derived iPSCs: recent advances and future potentials[J]. Brain Sci, 2025, 15(2): 134. DOI: 10.3390/brainsci15020134.
|
| [35] |
Lall D, Workman MJ, Sances S, et al. An organ-chip model of sporadic ALS using iPSC-derived spinal cord motor neurons and an integrated blood-brain-like barrier[J]. Cell Stem Cell, 2025, 32(7): 1139-1153.e7. DOI: 10.1016/j.stem.2025.05.015.
|
| [36] |
|
| [37] |
Grass T, Dokuzluoglu Z, Buchner F, et al. Isogenic patient-derived organoids reveal early neurodevelopmental defects in spinal muscular atrophy initiation[J]. Cell Rep Med, 2024, 5(8): 101659. DOI: 10.1016/j.xcrm.2024.101659.
|
| [38] |
Faravelli I, Rinchetti P, Tambalo M, et al. Targeted antisense oligonucleotide treatment rescues developmental alterations in spinal muscular atrophy organoids[J]. Nat Commun, 2025, 17(1): 988. DOI: 10.1038/s41467-025-67725-1.
|
| [39] |
Xu HJ, Yao Y, Yao F, et al. Generation of functional posterior spinal motor neurons from hPSCs-derived human spinal cord neural progenitor cells[J]. Cell Regen, 2023, 12(1): 15. DOI: 10.1186/s13619-023-00159-6.
|
| [40] |
Grass T, Dokuzluoglu Z, Rodríguez-Muela N. Neuromuscular organoids to study spinal cord development and disease[J]. Methods Mol Biol, 2025, 2951: 197-219. DOI: 10.1007/7651_2024_574.
|
| [41] |
Lee JH, Shaker MR, Park SH, et al. Transcriptional signature of valproic acid-induced neural tube defects in human spinal cord organoids[J]. Int J Stem Cells, 2023, 16(4): 385-393. DOI: 10.15283/ijsc23012.
|
| [42] |
Biancotti JC, Moore HE, Sescleifer AM, et al. Spinal cord organoids from human amniotic fluid iPSC recapitulate the diversity of cell phenotypes during fetal neural tube morphogenesis[J]. Mol Neurobiol, 2025, 62(8): 10954-10969. DOI: 10.1007/s12035-025-04944-z.
|
| [43] |
Ahuja CS, Wilson JR, Nori S, et al. Traumatic spinal cord injury[J]. Nat Rev Dis Primers, 2017, 3: 17018. DOI: 10.1038/nrdp.2017.18.
|
| [44] |
Boutom SM, Silva TP, Palecek SP, et al. Central nervous system vascularization in human embryos and neural organoids[J]. Cell Rep, 2024, 43(12): 115068. DOI: 10.1016/j.celrep.2024.115068.
|
| [45] |
Cakir B, Xiang YF, Tanaka Y, et al. Engineering of human brain organoids with a functional vascular-like system[J]. Nat Methods, 2019, 16(11): 1169-1175. DOI: 10.1038/s41592-019-0586-5.
|
| [46] |
Gao QM, Wang J, Zhang H, et al. Organoid vascularization: strategies and applications[J]. Adv Healthc Mater, 2025, 14(20): e2500301. DOI: 10.1002/adhm.202500301.
|
| [47] |
Park DS, Kozaki T, Tiwari SK, et al. iPS-cell-derived microglia promote brain organoid maturation via cholesterol transfer[J]. Nature, 2023, 623(7986): 397-405. DOI: 10.1038/s41586-023-06713-1.
|
| [48] |
Li XH, Hu N, Chang ZH, et al. Brain organoid maturation and implantation integration based on electrical signals input[J]. J Adv Res, 2025, 73: 375-395. DOI: 10.1016/j.jare.2024.08.035.
|
| [49] |
Hu N, Shi JX, Chen C, et al. Constructing organoid-brain-computer interfaces for neurofunctional repair after brain injury[J]. Nat Commun, 2024, 15(1): 9580. DOI: 10.1038/s41467-024-53858-2.
|
| [50] |
Sidhaye J, Knoblich JA. Brain organoids: an ensemble of bioassays to investigate human neurodevelopment and disease[J]. Cell Death Differ, 2021, 28(1): 52-67. DOI: 10.1038/s41418-020-0566-4.
|
| [51] |
Yang R, Qi Y, Zhang X, et al. Living biobank: standardization of organoid construction and challenges[J]. Chin Med J (Engl), 2024, 137(24): 3050-3060. DOI: 10.1097/cm9.0000000000003414.
|